News

Cathy Tie slips on a white lab coat bearing her name and the logo of her startup: Origin Genomics. "Welcome!" she says as she leads an NPR reporter, photographer and videographer on an exclusive tour of Origin's labs located...

This is the 17th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by Osagie K. Obasogie in...

THE INSTAGRAM POST, precision-guided by sex and age, had zeroed in on its target. Yuchen Tu is a conser­vatory-trained viola...

This is the 16th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring...

By Joseph Walker, Wall Street Journal | 05.03.2015
Untitled Document

Myriad Genetics Inc. used a patent-protected monopoly to become one of the most successful and controversial DNA testing...

By Leigh Turner, Trends in Molecular Medicine | 05.01.2015
Untitled Document

Clinics advertising adipose-derived autologous ‘stem cell treatments’ are proliferating across the USA. The rapid spread of businesses promoting...

By Jennifer Lynch, Electronic Frontier Foundation | 05.01.2015
Untitled Document

The New Orleans Advocate recently published a shocking story that details the very real threats to privacy and...

By UCA News, UCA News | 05.01.2015

China on Friday announced its latest crackdown on prenatal gender exams and illegal abortions despite further progress in narrowing the...

By Robert King, Washington Examiner | 04.30.2015
Untitled Document

Science is closer to creating genetically engineered human beings, and the advances in technology are sparking ethical arguments...

By Bioentrepreneur, Nature News Blog | 04.30.2015
Untitled Document

The organizers of a recent meeting in Napa, California, to consider the broad societal implications of clustered, regularly...

By James Gallagher, BBC | 04.30.2015
Untitled Document

Modifying the DNA of embryos is a "line that should not be crossed", a leading figure in US...

Press Statement
NIH Logo

The Center for Genetics and Society welcomes NIH Director Francis Collins' unambiguous statement that "altering the human germline in embryos for clinical purposes ...has been viewed almost universally as a line that should not be crossed," and his clarification of existing regulations relevant to germline gene editing research.

The policies and regulations that Dr. Collins enumerates provide some protection against rogue efforts to use germline modification techniques for reproductive purposes, although they do not rule out the use of private funding for germline alteration research. The United States currently has no codified legal prohibition against reproductive applications of human germline modification.

"The United States should join the dozens of other countries that have passed laws explicitly prohibiting the creation of genetically modified human beings," said CGS Executive Director Marcy Darnovsky, PhD. “We also need expanded international agreements, along the lines of the Council of Europe’s Convention on Biomedicine and Human Rights and UNESCO’s Universal Declaration on the Human Genome and Human Rights.”

As Dr. Collins notes, the arguments against genetically altering embryos or gametes for reproductive purposes are strong. In addition to those he mentions – serious safety issues, human experimentation without the possibility of consent, and the absence of medical justifications – we would add a set of broader social arguments.

There is no persuasive medical reason to manipulate the human germline because inherited genetic diseases can be prevented using embryo screening techniques, among other means. “Is the only justification for trying to refine germline gene editing the prospect of so-called enhancement?” Darnovsky asked. “Creating people with purported biological upgrades could all too easily exacerbate social inequality, discrimination and conflict. A decision to forgo human germline modification would protect our efforts toward a more just and equal society.”

####

The Center for Genetics and Society is a non-profit public affairs and policy advocacy organization working to encourage responsible uses and effective societal governance of human genetic and reproductive biotechnologies.


Contact:
Marcy Darnovsky
1-510-625-0819 x305
mdarnovsky[AT]geneticsandsociety[DOT]org